TenX Keane Acquisition(TENK) - 2024 Q4 - Annual Report
TenX Keane Acquisition(TENK)2024-12-27 22:00
The Company is responsible for preparing, filing, prosecuting, and maintaining all patent applications and patents included in the licensed patents that we intend to pursue within the territory. Obligations to Dr. Reddy's under the Asset Purchase Agreement 10 Also under the agreement with Dr. Reddy's, the Company is required to (i) use commercially reasonable efforts to make commercially available products in the CTCL indication, peripheral T-cell lymphoma indication and immuno-oncology indication, (ii) ini ...